₹901.40
−3.73%NSE close, 16 Nov 2026
+22.54%
Paras Healthcare is a small cap company, listed on NSE under the symbol PARASHLTH. At ₹901.40 a share, the market values the whole company at ₹9,753 crore.
₹ crore. Consolidated figures.
| Line | Sep 2026 |
|---|---|
| Sales | 511 |
| Expenses | 391 |
| Operating profit | 120 |
| Operating margin | 23.5% |
| Other income | 6.5 |
| Interest | 33.8 |
| Depreciation | 38.7 |
| Profit before tax | 54.2 |
| Tax | 13.9 |
| Net profit | 40.4 |
| EPS (₹) | 4.00 |
Transcript
Schedule of meet
Link of Recording
₹ crore, financial years to March.
Not filed yet.
₹ crore, at each year's end and the latest half year.
| Line | Sep 2026 |
|---|---|
| Shareholders’ equity | 486 |
| Borrowings | 979 |
| Total liabilities | 1,830 |
| Fixed assets | 651 |
| Investments | 0 |
| Cash and equivalents | 44.6 |
| Total assets | 2,316 |
₹ crore, by financial year, and the latest half year.
| Line | 6M to Sep 2026 |
|---|---|
| From operations | 68.2 |
| From investing | −134 |
| From financing | 63.1 |
| Spent on fixed assets | −90.2 |
| Free cash flow | −22.0 |
Margins, returns, debt, tax and cash.
Not filed yet.
Change in Director(s) of the company.
Paras Health reports robust revenue growth of 23% in Q2 YoY to Rs. 511 cr;EBITDA up 43% YoY; PAT up 3.3x YoY
The financial results for the period ended September 30, 2026.
Schedule of meet
Disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended ( SEBI SAST Regulations )
Disclosure under Regulation 30(5) of SEBI Listing Regulations
Code of Practices and Procedures for Fair Disclosure of UPSI under Regulation 8(2) SEBI PIT Regulations
Disclosure under Regulation 7(1) of SEBI Listing Regulations
Disclosure under Regulation 6(1) of SEBI Listing Regulations